Skip to main content
TYRA
NASDAQ Life Sciences

Tyra Prices $400M Offering at $22.03, Led by RA Capital

Tom Rudovsky · Reported by PR Newswire
More coverage: Biotech Stocks · Healthcare
Sentiment info
Neutral
Importance info
8
Price
$21.7
Mkt Cap
$1.315B
52W Low
$11.703
52W High
$40.65
52W Position info
85% above low
Off High info
47% below high
Rel. Volume info
1.8× avg
Market data snapshot near publication time

TYRA sits 85% above its 52-week low of $11.703 on elevated volume (1.8× avg).

Summary

Tyra Biosciences priced an underwritten offering of 9,079,000 common shares at $22.03 and 9,078,529 pre-funded warrants at $22.029, expecting gross proceeds of approximately $400 million. The offering is led by RA Capital Management with participation from Invus, Commodore Capital, BVF Partners, Janus Henderson Investors, and others. Proceeds will fund the dabogratinib 3x3 development strategy in LG-UTUC, IR NMIBC, and achondroplasia, plus preclinical programs and working capital. The deal is expected to close September 15, 2026. This follows the S-3ASR shelf filing earlier today and the FWP announcing the offering; pricing at $22.03 is a modest discount to the last close of $21.70, indicating strong institutional demand. The offering significantly dilutes existing shareholders but extends the cash runway well beyond the $353.9 million reported in Q2 2026.

Updates

  1. · SEC 424B5 — The 424B5 prospectus supplement sets net proceeds at approximately $373.9 million after underwriting discounts and estimated expenses, with delivery expected September 15, 2026.

At the time of this announcement, TYRA was trading at $21.70 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $1.3B. The 52-week trading range was $11.70 to $40.65. This news item was assessed with neutral market sentiment and an importance score of 8 out of 10. Source: PR Newswire.


Price Chart

Share this article

Copied!

TYRA - Latest Insights

TYRA
Nov 10, 2026, 8:05 AM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $22.25
Real-time Price: $20.02 info
Change: -$2.23 (-10%) info
Market Cap: $1.363B info
TYRA
Nov 10, 2026, 8:03 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $22.25
Real-time Price: $20.02 info
Change: -$2.23 (-10%) info
Market Cap: $1.363B info
TYRA
Sep 17, 2026, 4:32 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
7
Price at Filing: $24.43
Real-time Price: $20.02 info
Change: -$4.41 (-18%) info
Market Cap: $1.363B info
TYRA
Sep 14, 2026, 7:12 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $25.20
Real-time Price: $20.02 info
Change: -$5.18 (-21%) info
Market Cap: $1.363B info
TYRA
Sep 14, 2026, 7:09 PM EDT
Filing Type: 424B5
Importance Score:
8
Price at Filing: $25.20
Real-time Price: $20.02 info
Change: -$5.18 (-21%) info
Market Cap: $1.363B info